Epilepsy Monitoring Devices Market Outlook (2023 to 2033)

The epilepsy monitoring devices market size is projected to be valued at US$ 523.26 million in 2023. Whereas the market is expected to rise to US$ 894.63 million by 2033. The sales of epilepsy monitoring devices are likely to record a significant CAGR of 5.5% during the forecast period.

The senior population is more prone to epilepsy, and the global elderly population is expected to fuel market expansion.

Between 2015 and 2050, the global population of those over 60 is expected to nearly double, from 12 to 22%. According to research, more than 8% of the world's population is now above the age of 65.

Patients are increasingly interested in home epilepsy monitors, which allow them to monitor their condition from the comfort of their own homes. This has led to the development of wearable epilepsy monitors that can be used at home. Some companies use machine learning algorithms to analyze brain wave data to detect seizures.

Market players are focusing on product innovation and new product launches to meet the evolving needs of patients and healthcare professionals.

The market is also investing in research and development activities aimed at creating more accurate and effective epilepsy monitoring devices in the future.

Attribute Details
Epilepsy Monitoring Devices Market Estimated Size (2023) US$ 523.26 million
Epilepsy Monitoring Devices Market CAGR (2023 to 2033) 5.5%
Epilepsy Monitoring Devices Market Forecasted Size (2033) US$ 894.63 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Epilepsy Monitoring Devices from 2018 to 2022 Vs Market Outlook for 2023 to 2033

The epilepsy monitoring devices market has grown significantly in recent years. Owing to the rising prevalence of epilepsy, increased demand for minimally invasive diagnostic techniques, and the availability of improved monitoring technologies.

The integration of artificial intelligence (AI) and machine learning (ML) in epilepsy monitoring devices aid in the accurate diagnosis and treatment of epilepsy. In the next years, the growing use of telemedicine and remote monitoring solutions is likely to drive up demand for epilepsy monitoring devices.

Another factor that is predicted to contribute to the expansion of the market is the increase in government efforts and funding for research & development in the healthcare sector. Overall, the epilepsy monitoring devices market is predicted to rise rapidly in the next years, owing to the growing need for improved monitoring technologies. However, the market may encounter hurdles such as high device costs and a lack of awareness about these devices among patients. This may limit market growth to some extent. Considering this, FMI expects the global epilepsy monitoring devices market to record an absolute dollar growth of US$ 7.4 billion by 2033.

Trending Technologies which are Shaping the Epilepsy Monitoring Devices Market

  • Smart Helmets for Epilepsy Monitoring: the University of Melbourne researchers have created a smart helmet. It employs EEG sensors to monitor brain activity and detect seizures. Patients can wear the helmet at home, and it is linked to a smartphone app that warns carers in the event of a seizure.
  • Implantable Epilepsy Monitoring Devices: Several companies are developing implantable epilepsy monitoring devices that can enable continuous monitoring of brain activity and detect seizures in real-time. Neuropace, Inc., for example, has created the RNS System. An implantable device that monitors brain activity and offers focused electrical stimulation to avoid seizures.
  • Portable EEG devices are gaining popularity because they provide a non-invasive technique to monitor brain activity and detect seizures. Several firms, including Epilogue, have created portable EEG equipment that may be used at home and offer real-time seizure activity data.
  • Artificial intelligence (AI) and machine learning (ML) are being used by several firms to increase the accuracy of epilepsy monitoring equipment. Neurescue, for example, has created the Neurescue System, an AI-powered gadget that detects seizures and provides early intervention.
  • Mobile Apps for Epilepsy Monitoring: Mobile apps are becoming increasingly popular as a quick and simple approach to monitoring seizures. Several companies, including SeizAlarm, have created mobile apps that detect seizures and alert caregivers.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights of Epilepsy Monitoring Devices

On the Basis of Products, Wearable Devices are an Influencing Segment with a Growth Rate of 15.1%

The market share of wearable devices in the epilepsy monitoring devices industry is constantly increasing. Wearable gadgets, such as smartwatches, wristbands, and patches, are becoming increasingly popular. As they provide a convenient and non-invasive way to monitor seizures and collect data on seizure activity.

Wearable device adoption is being driven by various considerations, including portability, convenience of use, and the potential to offer real-time data on seizure activity. Wearable gadgets can also inform carers in the event of a seizure and provide useful insights into the frequency and length of seizures, which can aid in epilepsy management.

Conventional Devices hold a Prominent Share of 47% of Epilepsy Monitoring Devices in 2022

The devices have been in use for many years and are regarded as the gold standard for epilepsy diagnosis and management.

The significant market share of conventional equipment in the epilepsy monitoring devices market is due to several factors. Including its accuracy, dependability, and widespread availability. EEG and VEEG systems are frequently utilized in hospitals and clinics for the diagnosis and management of epilepsy and are widely accepted by healthcare experts.

While wearable gadgets and AI-powered systems are gaining popularity, traditional instruments such as EEG and VEEG systems remain the backbone of epilepsy monitoring.

Since epilepsy monitoring is generally performed in a hospital or specialized epilepsy center, hospitals have a substantial portion (45%) of the epilepsy monitoring equipment market. To diagnose and monitor patients with epilepsy, hospitals use advanced facilities such as EEG and VEEG devices.

Patients with epilepsy may require long-term monitoring to collect data on their seizures, which is usually done in a hospital or epilepsy center's epilepsy monitoring unit (EMU). Furthermore, hospitals and epilepsy centers have the required infrastructure and experience to undertake modern diagnostic tests and provide specialized care for epileptic patients. They have access to a variety of standard and advanced epilepsy monitoring devices, making them a prominent player in the epilepsy monitoring devices market.

Regional Analysis of the Market

North America Controls a Significant Market Share of 39% in the Market due to its Renowned Healthcare Solutions

The presence of leading manufacturers of epilepsy monitoring devices, favorable government initiatives, and the increasing adoption of advanced technologies. Such as AI-powered devices and wearable devices all contribute to North America's high share of the epilepsy monitoring devices market. Furthermore, the increased emphasis on patient-centered treatment and the growing need for home-based monitoring solutions are driving the growth of the North American market. The region is also experiencing a transition towards value-based care, which is projected to increase the usage of epilepsy monitoring devices even further.

According to FMI, Europe is a Prominent Market for Epilepsy Monitoring Devices Controlling a Market Share of 29%

The existence of prominent manufacturers of epilepsy monitoring devices, and favorable government measures to improve healthcare. Besides, the increasing acceptance of telemedicine for epilepsy care contributes to Europe's strong share of the epilepsy monitoring devices market. Furthermore, the increased emphasis on personalized and patient-centered care, as well as the growing need for home-based monitoring solutions, are driving the market. The region is also experiencing a transition towards value-based care, which is projected to increase the usage of epilepsy monitoring devices even further.

Cost-effectiveness is the Key Factor Bolstering the Asia Pacific Market. The Region is Witnessing a Growth Rate of 8.15%.

With an increasing market share, the Asia Pacific region is also an important market for epilepsy monitoring equipment. With the increasing prevalence of epilepsy, rising healthcare expenditure, and increased awareness of the ailment, the region is experiencing considerable growth in the market. Furthermore, the increased emphasis on patient-centric care and the growing need for home-based monitoring solutions are driving the growth of the Asia Pacific epilepsy monitoring devices market. The region is also experiencing a transition towards value-based care, which is projected to increase the usage of epilepsy monitoring devices even further.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

The epilepsy monitoring devices market is highly competitive, with several players operating in the market. Some key players in the market include:

  • Nihon Kohden Corporation
  • Medtronic PLC
  • General Electric Company
  • Koninklijke Philips N.V.
  • Compumedics Limited
  • Natus Medical Incorporated
  • EB Neuro S.p.A.
  • Cadwell Industries, Inc.
  • BrainScope Company, Inc.
  • LivaNova PLC

These companies are focusing on developing technologically advanced devices to provide better and accurate monitoring and diagnosis of epilepsy. They are also adopting various strategies such as partnerships, collaborations, acquisitions, and product launches to strengthen their market position and increase their market share.

The market is also witnessing the entry of several new players, which is intensifying the competition further. This is driving innovation and product development in the market, as companies are striving to differentiate themselves and gain a competitive edge.

Recent Developments

In May 2022, mjn-NEURO, a Spanish start-up, unveiled the mjn-SERAS. This aids in seizure detection in the United Kingdom. It is a game-changing technology that employs artificial intelligence to predict seizures up to three minutes in advance.

Epitel, a manufacturer of wearable electroencephalogram (EEG) technology, raised US$ 12.5 million in Series A funding in February 2022 for seizure detection.

Scope of the Report

Attribute Details
Growth Rate CAGR of 5.5% from 2023 to 2033
Base Year of Estimation 2023
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million and Volume in Units and F-CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis
Key Segments Covered Product Type, End User, By Region
Regions Covered North America; Latin America; Europe; East Asia; South Asia; Middle East & Africa; Oceania
Key Countries Profiled The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia
Key Companies Profiled Nihon Kohden Corporation; Medtronic PLC; General Electric Company; Koninklijke Philips N.V.; Compumedics Limited; Natus Medical Incorporated; EB Neuro S.p.A.; Cadwell Industries, Inc.; BrainScope Company, Inc.; LivaNova PLC
Customization & Pricing Available upon Request

Key Segments Covered in the Market Report

By Product:

  • Wearable Devices
  • Conventional Devices

By End User:

  • Hospitals
  • Ambulatory Surgery Centers and clinic
  • Neurology Centers
  • Diagnostic centers
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • The Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Epilepsy Monitoring Devices Market?

The market is valued at US$ 523.26 million in 2023.

What is the Growth Potential of the Epilepsy Monitoring Devices Market?

The growth potential of the epilepsy monitoring devices market is 5.5% CAGR through 2033.

How Big Might be the Epilepsy Monitoring Devices Market by 2033?

The market is estimated to reach US$ 894.63 million by 2033.

What are the Top Trending Technologies Driving the Market Growth?

Portable EEG devices, AI, ML, and smart helmets are expected to positively impact the epilepsy monitoring devices market.

Who are the Key Epilepsy Monitoring Devices Market Players?

Nihon Kohden Corporation, Medtronic PLC, and General Electric Company are key epilepsy monitoring devices market players.

Table of Content
1. Executive Summary | Epilepsy Monitoring Devices Market
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
        5.3.1. Wearable Devices
        5.3.2. Conventional Devices
    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
        6.3.1. Hospitals & Clinics
        6.3.2. Ambulatory Surgery Centres
        6.3.3. Neurology Centres
        6.3.4. Diagnostic Centres
    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Europe
        7.3.4. South Asia
        7.3.5. East Asia
        7.3.6. Oceania
        7.3.7. Middle East and Africa(MEA)
    7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        8.2.1. By Country
            8.2.1.1. USA
            8.2.1.2. Canada
        8.2.2. By Product
        8.2.3. By End User
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Product
        8.3.3. By End User
    8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Rest of Latin America
        9.2.2. By Product
        9.2.3. By End User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product
        9.3.3. By End User
    9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. United Kingdom
            10.2.1.3. France
            10.2.1.4. Spain
            10.2.1.5. Italy
            10.2.1.6. Rest of Europe
        10.2.2. By Product
        10.2.3. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product
        10.3.3. By End User
    10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. India
            11.2.1.2. Malaysia
            11.2.1.3. Singapore
            11.2.1.4. Thailand
            11.2.1.5. Rest of South Asia
        11.2.2. By Product
        11.2.3. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By End User
    11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. China
            12.2.1.2. Japan
            12.2.1.3. South Korea
        12.2.2. By Product
        12.2.3. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By End User
    12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. Australia
            13.2.1.2. New Zealand
        13.2.2. By Product
        13.2.3. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By End User
    13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. GCC Countries
            14.2.1.2. South Africa
            14.2.1.3. Israel
            14.2.1.4. Rest of Middle East and Africa(MEA)
        14.2.2. By Product
        14.2.3. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By End User
    14.4. Key Takeaways
15. Key Countries Market Analysis
    15.1. USA
        15.1.1. Pricing Analysis
        15.1.2. Market Share Analysis, 2022
            15.1.2.1. By Product
            15.1.2.2. By End User
    15.2. Canada
        15.2.1. Pricing Analysis
        15.2.2. Market Share Analysis, 2022
            15.2.2.1. By Product
            15.2.2.2. By End User
    15.3. Brazil
        15.3.1. Pricing Analysis
        15.3.2. Market Share Analysis, 2022
            15.3.2.1. By Product
            15.3.2.2. By End User
    15.4. Mexico
        15.4.1. Pricing Analysis
        15.4.2. Market Share Analysis, 2022
            15.4.2.1. By Product
            15.4.2.2. By End User
    15.5. Germany
        15.5.1. Pricing Analysis
        15.5.2. Market Share Analysis, 2022
            15.5.2.1. By Product
            15.5.2.2. By End User
    15.6. United Kingdom
        15.6.1. Pricing Analysis
        15.6.2. Market Share Analysis, 2022
            15.6.2.1. By Product
            15.6.2.2. By End User
    15.7. France
        15.7.1. Pricing Analysis
        15.7.2. Market Share Analysis, 2022
            15.7.2.1. By Product
            15.7.2.2. By End User
    15.8. Spain
        15.8.1. Pricing Analysis
        15.8.2. Market Share Analysis, 2022
            15.8.2.1. By Product
            15.8.2.2. By End User
    15.9. Italy
        15.9.1. Pricing Analysis
        15.9.2. Market Share Analysis, 2022
            15.9.2.1. By Product
            15.9.2.2. By End User
    15.10. India
        15.10.1. Pricing Analysis
        15.10.2. Market Share Analysis, 2022
            15.10.2.1. By Product
            15.10.2.2. By End User
    15.11. Malaysia
        15.11.1. Pricing Analysis
        15.11.2. Market Share Analysis, 2022
            15.11.2.1. By Product
            15.11.2.2. By End User
    15.12. Singapore
        15.12.1. Pricing Analysis
        15.12.2. Market Share Analysis, 2022
            15.12.2.1. By Product
            15.12.2.2. By End User
    15.13. Thailand
        15.13.1. Pricing Analysis
        15.13.2. Market Share Analysis, 2022
            15.13.2.1. By Product
            15.13.2.2. By End User
    15.14. China
        15.14.1. Pricing Analysis
        15.14.2. Market Share Analysis, 2022
            15.14.2.1. By Product
            15.14.2.2. By End User
    15.15. Japan
        15.15.1. Pricing Analysis
        15.15.2. Market Share Analysis, 2022
            15.15.2.1. By Product
            15.15.2.2. By End User
    15.16. South Korea
        15.16.1. Pricing Analysis
        15.16.2. Market Share Analysis, 2022
            15.16.2.1. By Product
            15.16.2.2. By End User
    15.17. Australia
        15.17.1. Pricing Analysis
        15.17.2. Market Share Analysis, 2022
            15.17.2.1. By Product
            15.17.2.2. By End User
    15.18. New Zealand
        15.18.1. Pricing Analysis
        15.18.2. Market Share Analysis, 2022
            15.18.2.1. By Product
            15.18.2.2. By End User
    15.19. GCC Countries
        15.19.1. Pricing Analysis
        15.19.2. Market Share Analysis, 2022
            15.19.2.1. By Product
            15.19.2.2. By End User
    15.20. South Africa
        15.20.1. Pricing Analysis
        15.20.2. Market Share Analysis, 2022
            15.20.2.1. By Product
            15.20.2.2. By End User
    15.21. Israel
        15.21.1. Pricing Analysis
        15.21.2. Market Share Analysis, 2022
            15.21.2.1. By Product
            15.21.2.2. By End User
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Product
        16.3.3. By End User
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. Boston Scientific Corporation
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
        17.1.2. Dragerwerk AG & Co. kGaA
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
        17.1.3. Abbott Laboratories Inc.
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
        17.1.4. Neurosoft
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
        17.1.5. Mindray Medical International Ltd.
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
        17.1.6. Cadwell Industries Inc.
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
        17.1.7. NeuroWave Systems
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
        17.1.8. Nihon Kohden Corporation
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
        17.1.9. Medtronic Plc
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
        17.1.10. Pfizer, Inc.
            17.1.10.1. Overview
            17.1.10.2. Product Portfolio
            17.1.10.3. Profitability by Market Segments
            17.1.10.4. Sales Footprint
            17.1.10.5. Strategy Overview
                17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Recommendations

Healthcare

Portable Medical Devices Market

February 2023

REP-GB-404

313 pages

Healthcare

Vital Signs Monitoring Devices Market

January 2023

REP-GB-410

333 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Epilepsy Monitoring Devices Market

Schedule a Call